Literature DB >> 16121196

Boat, an AXH domain protein, suppresses the cytotoxicity of mutant ataxin-1.

Akifumi Mizutani1, Lei Wang, Harini Rajan, Parminder J S Vig, William A Alaynick, Joshua P Thaler, Chih-Cheng Tsai.   

Abstract

Ataxin-1 is a neurodegenerative disorder protein whose glutamine-repeat expanded form causes spinocerebellar ataxia type 1 (SCA1) in humans and exerts cytotoxicity in Drosophila and mouse. We report here that the cytotoxicity caused by ataxin-1 is modulated by association with a related protein, Brother of ataxin-1 (Boat). Boat and ataxin-1 share a conserved AXH (ataxin-1 and HMG-box protein 1) domain, which is essential for both proteins' interactions with the transcriptional corepressor SMRT and its Drosophila homolog, SMRTER. The Boat-ataxin-1 interaction is mediated through multiple regions in both proteins, including a newly identified NBA (N-terminal region of Boat and ataxin-1) domain. We investigated the physiological relevance of the Boat-ataxin-1 interaction in Drosophila and discovered that a mutant ataxin-1-mediated eye defect is suppressed by ataxin-1's association with Boat. Correspondingly, in transgenic SCA1 mouse, Boat expression is greatly reduced in Purkinje cells, the primary targets of SCA1. Our study thus establishes that Boat is an in vivo binding partner of ataxin-1 whose altered expression in Purkinje cells may contribute to their degeneration in SCA1 animals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16121196      PMCID: PMC1224676          DOI: 10.1038/sj.emboj.7600785

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  31 in total

1.  Unique forms of human and mouse nuclear receptor corepressor SMRT.

Authors:  P Ordentlich; M Downes; W Xie; A Genin; N B Spinner; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

2.  The spinocerebellar ataxia type 1 protein, ataxin-1, has RNA-binding activity that is inversely affected by the length of its polyglutamine tract.

Authors:  S Yue; H G Serra; H Y Zoghbi; H T Orr
Journal:  Hum Mol Genet       Date:  2001-01-01       Impact factor: 6.150

3.  Genetic suppression of polyglutamine toxicity in Drosophila.

Authors:  P Kazemi-Esfarjani; S Benzer
Journal:  Science       Date:  2000-03-10       Impact factor: 47.728

Review 4.  Glutamine repeats and neurodegeneration.

Authors:  H Y Zoghbi; H T Orr
Journal:  Annu Rev Neurosci       Date:  2000       Impact factor: 12.449

5.  Identification of genes that modify ataxin-1-induced neurodegeneration.

Authors:  P Fernandez-Funez; M L Nino-Rosales; B de Gouyon; W C She; J M Luchak; P Martinez; E Turiegano; J Benito; M Capovilla; P J Skinner; A McCall; I Canal; H T Orr; H Y Zoghbi; J Botas
Journal:  Nature       Date:  2000-11-02       Impact factor: 49.962

Review 6.  Mouse and fly models of neurodegeneration.

Authors:  Huda Y Zoghbi; Juan Botas
Journal:  Trends Genet       Date:  2002-09       Impact factor: 11.639

7.  USP7, a ubiquitin-specific protease, interacts with ataxin-1, the SCA1 gene product.

Authors:  Sunghoi Hong; Sung-Jo Kim; Sojeong Ka; Inho Choi; Seongman Kang
Journal:  Mol Cell Neurosci       Date:  2002-06       Impact factor: 4.314

8.  Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice.

Authors:  Effat S Emamian; Michael D Kaytor; Lisa A Duvick; Tao Zu; Susan K Tousey; Huda Y Zoghbi; H Brent Clark; Harry T Orr
Journal:  Neuron       Date:  2003-05-08       Impact factor: 17.173

9.  Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1.

Authors:  Hung-Kai Chen; Pedro Fernandez-Funez; Summer F Acevedo; Yung C Lam; Michael D Kaytor; Michael H Fernandez; Alastair Aitken; Efthimios M C Skoulakis; Harry T Orr; Juan Botas; Huda Y Zoghbi
Journal:  Cell       Date:  2003-05-16       Impact factor: 41.582

10.  p80 coilin, a coiled body-specific protein, interacts with ataxin-1, the SCA1 gene product.

Authors:  Sunghoi Hong; Sojeong Ka; Sungjo Kim; Yongjae Park; Seongman Kang
Journal:  Biochim Biophys Acta       Date:  2003-05-20
View more
  40 in total

Review 1.  Current understanding on the pathogenesis of polyglutamine diseases.

Authors:  Xiao-Hui He; Fang Lin; Zheng-Hong Qin
Journal:  Neurosci Bull       Date:  2010-06       Impact factor: 5.203

2.  Gcn5 loss-of-function accelerates cerebellar and retinal degeneration in a SCA7 mouse model.

Authors:  Yi Chun Chen; Jennifer R Gatchel; Rebecca W Lewis; Chai-An Mao; Patrick A Grant; Huda Y Zoghbi; Sharon Y R Dent
Journal:  Hum Mol Genet       Date:  2011-10-14       Impact factor: 6.150

Review 3.  SCA1-phosphorylation, a regulator of Ataxin-1 function and pathogenesis.

Authors:  Harry T Orr
Journal:  Prog Neurobiol       Date:  2012-04-16       Impact factor: 11.685

Review 4.  The Capicua tumor suppressor: a gatekeeper of Ras signaling in development and cancer.

Authors:  Lucía Simón-Carrasco; Gerardo Jiménez; Mariano Barbacid; Matthias Drosten
Journal:  Cell Cycle       Date:  2018       Impact factor: 4.534

Review 5.  Pathogenic mechanisms of a polyglutamine-mediated neurodegenerative disease, spinocerebellar ataxia type 1.

Authors:  Huda Y Zoghbi; Harry T Orr
Journal:  J Biol Chem       Date:  2008-10-28       Impact factor: 5.157

6.  Atrophin recruits HDAC1/2 and G9a to modify histone H3K9 and to determine cell fates.

Authors:  Lei Wang; Bernard Charroux; Stephen Kerridge; Chih-Cheng Tsai
Journal:  EMBO Rep       Date:  2008-05-02       Impact factor: 8.807

7.  RNAi or overexpression: alternative therapies for Spinocerebellar Ataxia Type 1.

Authors:  Megan S Keiser; James C Geoghegan; Ryan L Boudreau; Kim A Lennox; Beverly L Davidson
Journal:  Neurobiol Dis       Date:  2013-04-10       Impact factor: 5.996

8.  Partial loss of ataxin-1 function contributes to transcriptional dysregulation in spinocerebellar ataxia type 1 pathogenesis.

Authors:  Juan Crespo-Barreto; John D Fryer; Chad A Shaw; Harry T Orr; Huda Y Zoghbi
Journal:  PLoS Genet       Date:  2010-07-08       Impact factor: 5.917

9.  Characterization of the zebrafish atxn1/axh gene family.

Authors:  Kerri M Carlson; Laura Melcher; Shaojuan Lai; Huda Y Zoghbi; H Brent Clark; Harry T Orr
Journal:  J Neurogenet       Date:  2008-12-10       Impact factor: 1.250

10.  Phosphorylation of S776 and 14-3-3 binding modulate ataxin-1 interaction with splicing factors.

Authors:  Cesira de Chiara; Rajesh P Menon; Molly Strom; Toby J Gibson; Annalisa Pastore
Journal:  PLoS One       Date:  2009-12-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.